Loading provider…
Loading provider…
Pulmonary Disease Physician in Dallas, TX
NPI: 1013093293Primary Practice Location
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
6201 Harry Hines Blvd, Dallas, TX
Primary Employer
University of Texas Southwestern Medical Center at Dallas
utswmed.org
HQ Phone
Get M.D. Sonja's Phone Numberphone_androidMobile
Get M.D. Sonja's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2010 - 2026

American Board of Internal Medicine
Critical Care Medicine

American Board of Internal Medicine
Pulmonary Disease
University of Kansas School of Medicine - Kansas City
kumc.edu
Medical School
Until 1999
Residency • Internal Medicine
1999 - 2002
Fellowship • Pulmonary Disease and Critical Care Medicine
2003 - 2006
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 37 | 103 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 36 | 45 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 26 | 26 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 13 | 13 |
| 5 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 11 | 33 |
Authors: Trushil Shah, Chandni Patel, Elizabeth Hardin, Fernando Torres, Kelly Chin
Journal: Chest
Publication Date: 2022-04-20
Thoracic Cavernous Lymphangioma Provoking Massive Chyloptysis: A Case Report
Authors: Carlos Girod, Cayce Harness-Brumley, John Dimaio
Journal: J Investig Med High Impact Case Rep
Publication Date: 2013-09-11
Inflammatory bowel diseases, chronic liver diseases and the lung.
Lead Sponsor: PhaseBio Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Pemziviptadil (PB1046) Injection
Lead Sponsor: PhaseBio Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Pemziviptadil (PB1046)
Lead Sponsor: Biogen
Intervention / Treatment: DRUG: Bardoxolone methyl